0001181431-13-059933.txt : 20131120
0001181431-13-059933.hdr.sgml : 20131120
20131120164447
ACCESSION NUMBER: 0001181431-13-059933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131118
FILED AS OF DATE: 20131120
DATE AS OF CHANGE: 20131120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLICKENSTAFF KIM D
CENTRAL INDEX KEY: 0001238913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 131233356
MAIL ADDRESS:
STREET 1: C/O MEDIVATION, INC.
STREET 2: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
rrd395712.xml
NOVEMBER 18, 2013 EXERCISE AND SALE
X0306
4
2013-11-18
0
0001011835
MEDIVATION, INC.
MDVN
0001238913
BLICKENSTAFF KIM D
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2013-11-18
4
M
0
30000
6.965
A
33557
D
Common Stock
2013-11-18
4
S
0
8100
60.57
D
25457
D
Common Stock
2013-11-18
4
S
0
14000
61.93
D
11457
D
Common Stock
2013-11-18
4
S
0
7900
62.54
D
3557
D
Stock Option (Right to Buy)
6.965
2013-11-18
4
M
0
30000
0.00
D
2018-06-15
Common Stock
30000
0
D
The shares were sold at prices ranging from $60.2567 to $61.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $61.285 to $62.27. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $62.275 to $62.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Patrick Machado, Attorney-in-fact
2013-11-19